Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Alimentary Pharmacology & Therapeutics|March 4, 2011
High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancyZ Zelinkova, C de Haar, L de Ridder, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2017
The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitisA Smolinska, A G L Bodelier, J W Dallinga, et al.
Alimentary Pharmacology & Therapeutics|October 15, 2013
Review article: the association of diet with onset and relapse in patients with inflammatory bowel diseaseC E G M Spooren, M J Pierik, M P Zeegers, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2016
High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitorsB P M Verhaegh, F de Vries, A A M Masclee, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2013
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitisB Flourié, H Hagège, G Tucat, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 1, 2017
[Changes in the treatment of Crohn's disease: fewer hospitalizations, less surgery, and reduced glucocorticoid use]S F G Jeuring, T R A van den Heuvel, M P Zeegers, et al.
Alimentary Pharmacology & Therapeutics|September 19, 2023
Abdominal pain in patients with inflammatory bowel disease in remission: A prospective study on contributing factorsL M Janssen, A Rezazadeh Ardabili, M J L Romberg-Camps, et al.
Alimentary Pharmacology & Therapeutics|May 24, 2023
Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel diseaseJ E Kreijne, R L Goetgebuer, N S Erler, et al.
Journal of Crohn'S & Colitis|November 5, 2020
Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease PhenotypesM D Voskuil, L M Spekhorst, K W J van der Sloot, et al.
Pageof 2